Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jeffrey Fessel

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Medical Hypotheses|December 21, 2004
A new approach to an AIDS vaccine: creating antibodies to HIV vif will enable apobec3G to turn HIV-infection into a benign problemW Jeffrey Fessel
AIDS (London, England)|July 4, 2009
Impaired neurocognition in HIV-infected patients: antecedents and treatmentW Jeffrey Fessel
AIDS (London, England)|January 25, 2003
Is HIV sequestered in bone? Possible implications of virological and immunological findings in some HIV-infected patients with bone diseaseW Jeffrey Fessel, Leo B Hurley
AIDS (London, England)|July 26, 2011
Association of osteonecrosis and osteoporosis in HIV-1-infected patientsW Jeffrey Fessel, Quyen Chau, Davis Leong
AIDS (London, England)|November 10, 2011
Association of osteonecrosis and peripheral neuropathy in HIV-1-infected patients: possible roles of nerve growth factor and vascular endothelial growth factorW Jeffrey Fessel, Quyen Chau, Davis Leong
AIDS (London, England)|September 10, 2002
High-density lipoprotein cholesterol is low in HIV-infected patients with lipodystrophic fat expansions: implications for pathogenesis of fat redistributionW Jeffrey Fessel, Stephen E Follansbee, John Rego
Medgenmed : Medscape General Medicine|April 5, 2007
Case files from Stanford University Medical Center: Drug resistance testing in previously untreated patients with HIV--knowing what to look for and choosing appropriate therapyRobert W Shafer, Dong Phuong Nguyen, W Jeffrey Fessel
Mycoses|March 4, 2005
Cryptococcosis: the 1981-2000 epidemicGary D Friedman, W Jeffrey Fessel, Natalia V Udaltsova, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2009
Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vectorElizabeth C Reuman, Michael H Bachmann, Vici Varghese, et al.
The Journal of Infectious Diseases|October 24, 2007
Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatmentYumi Mitsuya, Tommy F Liu, Soo-Yon Rhee, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Medical Hypotheses|December 21, 2004
A new approach to an AIDS vaccine: creating antibodies to HIV vif will enable apobec3G to turn HIV-infection into a benign problemW Jeffrey Fessel
AIDS (London, England)|July 4, 2009
Impaired neurocognition in HIV-infected patients: antecedents and treatmentW Jeffrey Fessel
AIDS (London, England)|January 25, 2003
Is HIV sequestered in bone? Possible implications of virological and immunological findings in some HIV-infected patients with bone diseaseW Jeffrey Fessel, Leo B Hurley
AIDS (London, England)|July 26, 2011
Association of osteonecrosis and osteoporosis in HIV-1-infected patientsW Jeffrey Fessel, Quyen Chau, Davis Leong
AIDS (London, England)|November 10, 2011
Association of osteonecrosis and peripheral neuropathy in HIV-1-infected patients: possible roles of nerve growth factor and vascular endothelial growth factorW Jeffrey Fessel, Quyen Chau, Davis Leong
AIDS (London, England)|September 10, 2002
High-density lipoprotein cholesterol is low in HIV-infected patients with lipodystrophic fat expansions: implications for pathogenesis of fat redistributionW Jeffrey Fessel, Stephen E Follansbee, John Rego
Medgenmed : Medscape General Medicine|April 5, 2007
Case files from Stanford University Medical Center: Drug resistance testing in previously untreated patients with HIV--knowing what to look for and choosing appropriate therapyRobert W Shafer, Dong Phuong Nguyen, W Jeffrey Fessel
Mycoses|March 4, 2005
Cryptococcosis: the 1981-2000 epidemicGary D Friedman, W Jeffrey Fessel, Natalia V Udaltsova, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2009
Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vectorElizabeth C Reuman, Michael H Bachmann, Vici Varghese, et al.
The Journal of Infectious Diseases|October 24, 2007
Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatmentYumi Mitsuya, Tommy F Liu, Soo-Yon Rhee, et al.
Pageof 5